<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04291521</url>
  </required_header>
  <id_info>
    <org_study_id>APP-20-00661</org_study_id>
    <nct_id>NCT04291521</nct_id>
  </id_info>
  <brief_title>Prospective Study of Induction Medications Used in the Trauma RSI</brief_title>
  <acronym>ProTIM</acronym>
  <official_title>Prospective Study of Induction Medications Used in the Rapid Sequence Intubation of Trauma Patients and a Comparison of Effects on Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents
      for adult trauma patients undergoing intubation within 24 hours of admission. The primary
      goal is to determine the ideal agent that should be used in this patient population for
      intubations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale:

      Although rapid sequence intubation (RSI) is commonly used in the emergency department (ED) or
      operating room (OR) for trauma patients, there is not one induction medication which has been
      deemed the drug of choice for this particular use. There is a wide variation in induction
      agents used by providers performing RSIs, including propofol, ketamine, methohexital,
      midazolam, fentanyl, and etomidate. However, no society guidelines exist on the induction
      agent of choice in trauma for either hemodynamically stable or unstable patients. The purpose
      of this study is to compare the effects of 3 of the most commonly used induction agents
      (propofol, etomidate, and ketamine) for RSIs in adult trauma patients on outcomes, such as
      mortality, and hemodynamic status. Ultimately, the investigators would like to lay the
      groundwork for developing guidelines that define the ideal induction agent for trauma RSIs.

      Intervention: Giving propofol, ketamine, or etomidate as the induction medication for a rapid
      sequence intubation in trauma patients requiring intubation within 24 hours of admission.

      Objectives/Purpose: The purpose of this study is to compare the effects of 3 of the most
      commonly used induction agents (propofol, etomidate, and ketamine) for RSIs in adult trauma
      patients on outcomes such as mortality. Additionally, how each agent effects patients'
      hemodynamic status will be evaluated. Additional outcomes of these medications will be
      studied in three subsets of patients: 1. those with traumatic brain injuries, 2. elderly
      patients (&gt;=65-years-old), and 3. those with a low shock index (&lt;0.9) compared to a high
      shock index (&gt;0.9). Finally, the practices and outcomes of RSIs performed in the ED versus
      the OR will be compared. Ultimately, the investigators would like to lay the groundwork for
      developing guidelines that define the ideal induction agent for trauma RSIs.

      Study population: Adult trauma patients undergoing RSI within 24 hours of hospital admission

      Methodology: A multicenter, prospective observational study will be performed.

      Endpoints: In-hospital mortality, 28-day mortality, ICU and total hospital length of stay,
      complications, hypotension and vasopressor use 30 minutes and 24 hours after intubation,
      mechanical ventilator days, and discharge disposition

      Statistic plan: Data will be entered into a password-protected online data collection tool
      known as RedCap, and analyzed using SAS version 9.4 (SAS Institute, Inc., Cary, NC).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 30, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>in-hospital mortality</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total hospital length of stay</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intensive care unit length of stay</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mechanical ventilator days</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with hypotension</measure>
    <time_frame>30 minutes after intubation</time_frame>
    <description>defined as systolic blood pressure&lt;90 mmHg or mean arterial pressure &lt;50 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with hypotension</measure>
    <time_frame>24 hours after intubation</time_frame>
    <description>defined as systolic blood pressure&lt;90 mmHg or mean arterial pressure &lt;50 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants requiring vasopressor use</measure>
    <time_frame>30 minutes after intubation</time_frame>
    <description>vasopressor use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants requiring vasopressor use</measure>
    <time_frame>24 hours post intubation</time_frame>
    <description>vasopressor use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of complications</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>examples: adrenal insufficiency, aspiration, pneumonia, acute respiratory distress syndrome, organ failure, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days after admission</time_frame>
    <description>28 day mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>discharge disposition</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>examples: discharge home no services, home with services, skilled nursing facility, rehabilitation center, etc.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Trauma</condition>
  <condition>Rapid Sequence Intubation</condition>
  <arm_group>
    <arm_group_label>Adult trauma patients requiring RSI</arm_group_label>
    <description>Patients who received an induction medication for intubation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Administering ketamine as an induction medication for intubating adult trauma patients within 24 hours of hospital admission.</description>
    <arm_group_label>Adult trauma patients requiring RSI</arm_group_label>
    <other_name>Ketalar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate</intervention_name>
    <description>Administering etomidate as an induction medication for intubating adult trauma patients within 24 hours of hospital admission.</description>
    <arm_group_label>Adult trauma patients requiring RSI</arm_group_label>
    <other_name>Amidate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Administering propofol as an induction medication for intubating adult trauma patients within 24 hours of hospital admission.</description>
    <arm_group_label>Adult trauma patients requiring RSI</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult trauma patients requiring intubation within 24 hours of hospital admission.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Trauma patients &gt;=18 yo requiring intubation within 24 hours of admission in either
             the ED or OR

          -  Patients received propofol, etomidate, or ketamine for induction agent

        Exclusion Criteria:

          -  Patients who were intubated without induction agent medications

          -  Patients intubated outside of the hospital or in the field

          -  Patients who were intubated with an induction agent other than etomidate, ketamine, or
             propofol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine M Kuza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keck School of Medicine of the University of Southern California</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Catherine M Kuza, MD</last_name>
    <phone>9089176330</phone>
    <email>catherine.kuza@med.usc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeffry T Nahmias, MD</last_name>
    <phone>9493073035</phone>
    <email>jnahmias@uci.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Keck School of Medicine of the University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Banh KV, James S, Hendey GW, Snowden B, Kaups K. Single-dose etomidate for intubation in the trauma patient. J Emerg Med. 2012 Nov;43(5):e277-82. doi: 10.1016/j.jemermed.2012.02.027. Epub 2012 May 3.</citation>
    <PMID>22560133</PMID>
  </reference>
  <reference>
    <citation>Jabre P, Combes X, Lapostolle F, Dhaouadi M, Ricard-Hibon A, Vivien B, Bertrand L, Beltramini A, Gamand P, Albizzati S, Perdrizet D, Lebail G, Chollet-Xemard C, Maxime V, Brun-Buisson C, Lefrant JY, Bollaert PE, Megarbane B, Ricard JD, Anguel N, Vicaut E, Adnet F; KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet. 2009 Jul 25;374(9686):293-300. doi: 10.1016/S0140-6736(09)60949-1. Epub 2009 Jul 1.</citation>
    <PMID>19573904</PMID>
  </reference>
  <reference>
    <citation>Hinkewich C, Green R. The impact of etomidate on mortality in trauma patients. Can J Anaesth. 2014 Jul;61(7):650-5. doi: 10.1007/s12630-014-0161-6. Epub 2014 Apr 11.</citation>
    <PMID>24723214</PMID>
  </reference>
  <reference>
    <citation>Hohl CM, Kelly-Smith CH, Yeung TC, Sweet DD, Doyle-Waters MM, Schulzer M. The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review. Ann Emerg Med. 2010 Aug;56(2):105-13.e5. doi: 10.1016/j.annemergmed.2010.01.030. Epub 2010 Mar 25. Review.</citation>
    <PMID>20346542</PMID>
  </reference>
  <reference>
    <citation>McPhee LC, Badawi O, Fraser GL, Lerwick PA, Riker RR, Zuckerman IH, Franey C, Seder DB. Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: analysis of a large electronic ICU database. Crit Care Med. 2013 Mar;41(3):774-83. doi: 10.1097/CCM.0b013e318274190d.</citation>
    <PMID>23318491</PMID>
  </reference>
  <reference>
    <citation>Warner KJ, Cuschieri J, Jurkovich GJ, Bulger EM. Single-dose etomidate for rapid sequence intubation may impact outcome after severe injury. J Trauma. 2009 Jul;67(1):45-50. doi: 10.1097/TA.0b013e3181a92a70.</citation>
    <PMID>19590307</PMID>
  </reference>
  <reference>
    <citation>Upchurch CP, Grijalva CG, Russ S, Collins SP, Semler MW, Rice TW, Liu D, Ehrenfeld JM, High K, Barrett TW, McNaughton CD, Self WH. Comparison of Etomidate and Ketamine for Induction During Rapid Sequence Intubation of Adult Trauma Patients. Ann Emerg Med. 2017 Jan;69(1):24-33.e2. doi: 10.1016/j.annemergmed.2016.08.009.</citation>
    <PMID>27993308</PMID>
  </reference>
  <reference>
    <citation>Fields AM, Rosbolt MB, Cohn SM. Induction agents for intubation of the trauma patient. J Trauma. 2009 Oct;67(4):867-9. doi: 10.1097/TA.0b013e3181b021c5. Review.</citation>
    <PMID>19820598</PMID>
  </reference>
  <reference>
    <citation>Baird CR, Hay AW, McKeown DW, Ray DC. Rapid sequence induction in the emergency department: induction drug and outcome of patients admitted to the intensive care unit. Emerg Med J. 2009 Aug;26(8):576-9. doi: 10.1136/emj.2008.067801.</citation>
    <PMID>19625554</PMID>
  </reference>
  <reference>
    <citation>Zettervall SL, Sirajuddin S, Akst S, Valdez C, Golshani C, Amdur RL, Sarani B, Dunne JR. Use of propofol as an induction agent in the acutely injured patient. Eur J Trauma Emerg Surg. 2015 Aug;41(4):405-11. doi: 10.1007/s00068-014-0479-3. Epub 2014 Nov 20.</citation>
    <PMID>26038005</PMID>
  </reference>
  <reference>
    <citation>Choi YF, Wong TW, Lau CC. Midazolam is more likely to cause hypotension than etomidate in emergency department rapid sequence intubation. Emerg Med J. 2004 Nov;21(6):700-2.</citation>
    <PMID>15496697</PMID>
  </reference>
  <reference>
    <citation>Morris C, Perris A, Klein J, Mahoney P. Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia. 2009 May;64(5):532-9. doi: 10.1111/j.1365-2044.2008.05835.x. Review.</citation>
    <PMID>19413824</PMID>
  </reference>
  <reference>
    <citation>Miller M, Kruit N, Heldreich C, Ware S, Habig K, Reid C, Burns B. Hemodynamic Response After Rapid Sequence Induction With Ketamine in Out-of-Hospital Patients at Risk of Shock as Defined by the Shock Index. Ann Emerg Med. 2016 Aug;68(2):181-188.e2. doi: 10.1016/j.annemergmed.2016.03.041. Epub 2016 Apr 27.</citation>
    <PMID>27130803</PMID>
  </reference>
  <reference>
    <citation>Lyon RM, Perkins ZB, Chatterjee D, Lockey DJ, Russell MQ; Kent, Surrey &amp; Sussex Air Ambulance Trust. Significant modification of traditional rapid sequence induction improves safety and effectiveness of pre-hospital trauma anaesthesia. Crit Care. 2015 Apr 1;19:134. doi: 10.1186/s13054-015-0872-2.</citation>
    <PMID>25879683</PMID>
  </reference>
  <reference>
    <citation>Kolenda H, Gremmelt A, Rading S, Braun U, Markakis E. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien). 1996;138(10):1193-9. Erratum in: Acta Neurochir (Wien) 1997;139(12):1193.</citation>
    <PMID>8955439</PMID>
  </reference>
  <reference>
    <citation>Bourgoin A, Alban√®se J, Wereszczynski N, Charbit M, Vialet R, Martin C. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med. 2003 Mar;31(3):711-7.</citation>
    <PMID>12626974</PMID>
  </reference>
  <reference>
    <citation>Hughes S. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: is ketamine a viable induction agent for the trauma patient with potential brain injury. Emerg Med J. 2011 Dec;28(12):1076-7. doi: 10.1136/emermed-2011-200891. Review.</citation>
    <PMID>22101599</PMID>
  </reference>
  <results_reference>
    <citation>Bergen JM, Smith DC. A review of etomidate for rapid sequence intubation in the emergency department. J Emerg Med. 1997 Mar-Apr;15(2):221-30. Review.</citation>
    <PMID>9144065</PMID>
  </results_reference>
  <results_reference>
    <citation>Pillay L, Hardcastle T. Collective Review of the Status of Rapid Sequence Intubation Drugs of Choice in Trauma in Low- and Middle-Income Settings (Prehospital, Emergency Department and Operating Room Setting). World J Surg. 2017 May;41(5):1184-1192. doi: 10.1007/s00268-016-3712-x. Review.</citation>
    <PMID>27646281</PMID>
  </results_reference>
  <results_reference>
    <citation>Mayglothling J, Duane TM, Gibbs M, McCunn M, Legome E, Eastman AL, Whelan J, Shah KH; Eastern Association for the Surgery of Trauma. Emergency tracheal intubation immediately following traumatic injury: an Eastern Association for the Surgery of Trauma practice management guideline. J Trauma Acute Care Surg. 2012 Nov;73(5 Suppl 4):S333-40. doi: 10.1097/TA.0b013e31827018a5.</citation>
    <PMID>23114490</PMID>
  </results_reference>
  <results_reference>
    <citation>Ballow SL, Kaups KL, Anderson S, Chang M. A standardized rapid sequence intubation protocol facilitates airway management in critically injured patients. J Trauma Acute Care Surg. 2012 Dec;73(6):1401-5. doi: 10.1097/TA.0b013e318270dcf5.</citation>
    <PMID>23188232</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>February 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2020</study_first_posted>
  <last_update_submitted>February 27, 2020</last_update_submitted>
  <last_update_submitted_qc>February 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern California</investigator_affiliation>
    <investigator_full_name>Catherine Kuza</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>trauma</keyword>
  <keyword>induction medications</keyword>
  <keyword>rapid sequence intubations</keyword>
  <keyword>outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

